A Phase III Double-Blind Randomised Trial of Rectal Sucralfate Suspension in the Treatment of Radiation Proctitis

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to

26 March, 2026

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific